Stockreport

Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results

Vir Biotechnology, Inc.  (VIR) 
PDF – Late-breaker SOLSTICE data abstract accepted for poster presentation at the European Association for the Study of the Liver (EASL) Congress 2024 –– Two additional hepa [Read more]